Transpek Industry Limited · BSE:TRANSPEK
Transpek Industry — Investor Presentation (August 2021)
36 slides from Transpek Industry's investor presentation, Aug 19, 2021
Slide 1: Cover letter to BSE for investor presentation
! +91 265 2335444, 2335757, 2358236 ! 2342262, 2334141 !PHONE +91 2 6 5 2 3 3 5 75 8i ..... F A X! Transpek Industry Limited vTraospef\ - Off : 4111 floor, LIUerta 1038., Gotrt Sevasl Roa�, · . Vldodall • 390021: Gujarat (India) rcative Cherni�1ry Ph, : 0265-6700300 • 301 Date: 19th August, 2021 To,
Slide 2: Transpek Industry Limited Investor Presentation August 2021
Transpek Industry Limited Investor Presentation August 2021
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Transpek Industry Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se
Slide 4: Q1 FY22 - Financial Highlights
Q1 FY22 - Financial Highlights
Slide 5: Business Highlights
Business Highlights Business performance has seen a significant improvement over the last two quarters. The revenues in Q1FY22 was better as compared to Q4FY21 and Q1FY21. The application volumes are gradually restoring providing opportunity for the company to increase its revenue. As a strategic mo
Slide 6: Sequential Improvement in Performance
Sequential Improvement in Performance Q1 FY22 Sales Distribution Revenue* (Rs. In Cr) based on Application 13.7% Polymer 14.7% Pharma 132.0 59.2% Specialty 12.4% 101.2 Others 95.7 79.6 80.3 Q1 FY22 - Revenue Breakup Q1FY21 Q2FY21 Q3FY21 Q4FY21 Q1 FY22 24.5% International EBITDA* (Rs. In Cr) PAT (Rs.
Slide 7: Q1 FY22 – Consolidated Profit & Loss Account
Q1 FY22 – Consolidated Profit & Loss Account Particulars (Rs. Crores) Q1FY22 Q1FY21 Y-o-Y Q4FY21 Q-o-Q Revenue from Operations 121.7 74.7 96.5 Other Income 10.3 4.9 4.7 Total Revenue from operations 132.0 79.6 65.8% 101.2 30.4% Cost of materials consumed 64.3 32.7 44.3 Purchases of stock-in-trade 0.
Slide 8: FAQ’s
FAQ’s • As announced earlier, the new project has been put on hold. The management periodically reviews the situation and would announce any significant change in the status. Project & Capex • The Capex for next two years will be based on the timing of the introduction of new products and any signif
Slide 9: Transpek at Glance
Transpek at Glance
Slide 10: About us
About us Environment Protection Founded by Shri. Govindji Shroff in 1965 Over 5 decades Creative Over three Part of Excel experience in Chemistry decades of presence in the group of Sulphur and international companies Chlorine market Chemistry Customer Exploring every Headquartered Focus possible in
Slide 11: Our journey over five decades
Our journey over five decades 2017 Long term supply agreement with global chemical giant 2018 Started supplying under long 2004 term supply agreement and Set up of First Multi Purpose became big global player in acid Acid Chloride Plant chlorides 2012 1987 Significant strategic shift from Started ma
Slide 12: Our products are supplied to varied industries
Our products are supplied to varied industries Q4 FY21 Sales Distribution based on Application Leading global supplier for ‘Chlorinated Products’ to various industry sectors ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. 14.9% Polymer Polymers Pharma Specialty Chemicals Pharma 18.
Slide 13: Our products have multiple applications
Our products have multiple applications Diversified Products Across India’s Fastest Growing Industries • 2, 4, 6 Trimethyl Benzoyl • 2-Methoxyethyl chloride • 2-Chloroethylamine • 2-Chloroethylamine Chloride • Cocoyl Chloride • 2-Propoxyethyl chloride Hydrochloride Solution Hydrochloride Solution •
Slide 14: Our capabilities developed over years
Our capabilities developed over years Research & Development Sustainability Ratings ◊ In house development of products ◊ ECOVADIS Sustainability platform – the company is ◊ DSIR approved R&D Facility rated very high with ‘Silver Badge’ ◊ R&D Lab approved by MS University of Baroda for ◊ One of those
Slide 15: Our clients trust in our capabilities & chemistries
Our clients trust in our capabilities & chemistries Company has built an excellent reputation globally – Testament to our Reliability and Trustworthiness Long-term supply agreement commenced from 1st January 2018 Contract 10 years Period Exclusive contract with a High performance product with dedica
Slide 16: Our plants are multipurpose and multiproduct
Our plants are multipurpose and multiproduct Ekalbara Located ~25 km away from the headquarter location at Vadodara, Gujarat. Dedicated multipurpose and multiproduct plants spread over 100 acres with total production capacity of 66,000 • Strategically located in largest chemical MTPA. manufacturing
Slide 17: Our R & D facility is recognized by Government of India
Our R & D facility is recognized by Government of India Research & Development Developed a comprehensive in-house R&D facility recognized by the Department of Science & Technology, Government of India, which is equipped with latest technology and equipment Every new and existing product undergoes a
Slide 18: Our top management is committed to process safety
Our top management is committed to process safety PHA Chemical Release • Process Hazard Analysis 01 • Dispersion Modeling Studies conducted for all products and • Storage Quantity Reduction processes 02 • Mechanical Integrity of Equipment Top Management 06 PSSR • Total commitment and • Pre-Startup s
Slide 19: Our transportation is safe, systematic and sustainable
Our transportation is safe, systematic and sustainable Logistics Safe, systematic and sustainable transportation is a key challenge to ever changing global chemical industry Pioneers in developing in-house ISO Tank station which is well equipped with state-of-the-art technology We manage over 600 IS
Slide 20: Our products are delivered across the globe
Our products are delivered across the globe One of the Pioneering Global Exporters from India since 1986 FY21 - Revenue Breakup Long term relations with Leading Global Chemical Giants 25% Sweden 75% Spain Germany Russia France Italy Switzerland Domestic International U.S.A. Japan China South Korea T
Slide 21: Our board has vast industry experience
Our board has vast industry experience Mr. Ashwin C. Shroff | Chairman Mr. Bernd Dill | Independent Director He is a science graduate, Mr. Shroff have emerged stronger, helping the growth of He is a German national, having emphasis on mathematics and natural sciences, Doctoral Industrial chemicals,
Slide 22: Our company has adopted a sustainable method of doing business
Our company has adopted a sustainable method of doing business Community Empowerment Biodiversity Serving the society in various areas Maintaining and enhancing green belt (flora and like health & hygiene, education, skill fauna) within the factory premises through development, vocational training e
Slide 23: ESG at the heart of all we do
ESG at the heart of all we do
Slide 24: Corporate social responsibility
Corporate social responsibility Women Empowerment Workshops Vocational Training Understanding the needs of communities, addressing them Our vision is to actively contribute towards through need-based projects and making them work together creating innovative and sustainable solutions in to help crea
Slide 25: Awards and Recognitions – A glimpse
Awards and Recognitions – A glimpse Government of Gujarat: FGI Award for Excellence in the field of Indian Chemical Council: Excellence in CSR Award Environment Pollution Abatement & Best in Social Responsibility Award Preservation Shri Atul Shroff MD & Union Leader Shri Ashok Shri Bimal V. Mehta, E
Slide 26: Environment, health and safety
Environment, health and safety Rainwater harvesting and recharging Green cover in Transpek premise Safety is our responsibility We have Full-fledged Effluent management system with a licensed discharge facility to the central Effluent channel Our company has 100 acres of land with a green belt of mo
Slide 27: Socially responsible at the time of COVID – 19
Socially responsible at the time of COVID – 19 Activities done during COVID-19: Arranged for immunity boosting medicines including multi vitamins, zinc and iron sucrose injections, as per the requirements of Primary Health Centre – Mujpur, along with gloves and sanitizer bottles for their health sta
Slide 28: Historical Financial Highlights
Historical Financial Highlights
Slide 29: FY21 – Consolidated Profit & Loss Account
FY21 – Consolidated Profit & Loss Account Particulars (Rs. Crores) FY21 FY20 Y-o-Y Revenue from Operations 339.4 565.6 Other Income 17.3 17.4 Total Revenue from operations 356.7 583.0 -38.8% Cost of materials consumed 159.3 253.1 Purchases of stock-in-trade 0.0 0.0 Changes in inventories of finished
Slide 30: Mar’21 - Consolidated Balance Sheet
Mar’21 - Consolidated Balance Sheet Liabilities (Rs. Crores) Mar-21 Mar-20 Assets (Rs. Crores) Mar-21 Mar-20 Equity Non Current assets Equity Share capital 5.6 5.6 Property, Plant and Equipment 271.5 270.7 Other Equity 374.2 332.9 Capital work-in-progress 13.9 18.6 Right to use of lease assets 15.6
Slide 31: Mar’21 - Consolidated Cash Flow Statement
Mar’21 - Consolidated Cash Flow Statement Particulars (Rs. Crores) Mar-21 Mar-20 Net Profit Before Tax 25.5 93.5 Adjustments for: Non Cash Items / Other Investment or Financial Items 33.6 39.3 Operating profit before working capital changes 59.1 132.8 Changes in working capital 2.4 2.0 Cash generate
Slide 32: Consolidated Financial Highlights
Consolidated Financial Highlights Revenue* (Rs. In Cr) EBITDA* (Rs. In Cr) PAT (Rs. In Cr) 18.6% 15.3% 21.9% 23.2% 18.1% 9.3% 7.1% 10.7% 12.5% 6.5% Margin 612.4 583.0 150 134.4 135.3 80 73.0 65.7 60 370.9 356.7 100 324.0 60.2 56.9 64.4 40 30.0 26.4 23.3 50 20 0 0 FY17 FY18 FY19 FY20 FY21 FY17 FY18 F
Slide 33: Consistent Dividend Performance
Consistent Dividend Performance Dividend Dividend Per Share 220 27 200% 200 180 20.0 160 18 140 125% 120 100 90% 90% 12.5 80 75% 75% 9 60 9.0 9.0 50% 7.5 7.5 40 25% 2.5 5.0 20 0 0 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 32
Slide 34: Way Forward
Way Forward
Slide 35: Growth Initiatives
Growth Initiatives • The company is focusing on reducing customer, product and regional concentration. • It is to be noted that customer/product concentration has helped company to improve its performance significantly in 2018-19 and 2019-20 bringing in stability and financial strength. However, con
Slide 36: THANK YOU
Contact Information Company : Investor Relations Advisor : Transpek Industry Limited Strategic Growth Advisors Pvt. Ltd. CIN: L23205GJ1965PLC001343 CIN: U74140MH2010PTC204285 Mr. Alak D. Vyas Mr. Shrikant Sangani / Ms. Pankti Majithia E: shrikant.sangani@sgapl.net / pankti.majithia@sgapl.net E: secr
Transpek Industry — Investor Presentation (August 2021) on 6ix